G

Galectin Therapeutics
D

GALT

2.97300
USD
-0.09
(-2.84%)
مغلق
حجم التداول
10,849
الربح لكل سهم
-0
العائد الربحي
-
P/E
-5
حجم السوق
191,484,192
أصول ذات صلة المقالات

العنوان: Galectin Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.